Protein kinase C gamma (PKC gamma) is a major isoform of PKC in the lens epithelium and cortex. This PKC phosphorylates the lens gap junction protein, Cx43, causing inhibition of gap junction activity. PKC gamma is specifically decreased during galactosemia, in streptozotocin diabetic rats, and in human diabetic lens. This decrease in PKC gamma would result in an increase in gap junction activity.
The specific aims of this proposal are: 1) To determine how PKC gamma is controlled in normal lens epithelial cells by EGF, and by translocation, downregulation, turnover, and expression in response to lipid and calcium. 2) To determine how the control of PKC gamma alters gap junction activity through changes in Cx43 phosphorylation, gap junction activity, and gap junction assembly.
Specific aims 1 and 2 will utilize lens cells in culture, overexpression systems, green fluorescent protein-PKC gamma (gfp-PKC gamma), gfp-cys-1 and 2 domains (lipid binding domains of PKC gamma), confocal microscopy, and biochemical studies of PKC gamma regulation. 3) To determine how PKC gamma is decreased during galactosemia and diabetes, and how this decrease affects the gap junctions. These studies will be done in galactosemic and streptozotocin diabetic rats, will include studies on Cx43 and Cx46, and will focus on the lens cortical swelling region which is observed in the rat diabetic model. Changes in gap junction activity have been reported to occur in numerous tissues during diabetes. We have identified PKC gamma as a control point for lens gap junction activity and have determined that this isoform is decreased during diabetes and galactosemia and in human diabetic lens. PKC gamma levels can be restored to normal with an aldose reductase inhibitor, suggesting the presence of osmotic response elements in the PKC gamma gene. When PKC gamma is decreased, the control of lens gap junctions may be lost, resulting in damage to the diabetic lens cell. The control of PKC gamma in normal cells and the loss of control in diabetes are the subject of this proposal. This information will provide direction for the design of drugs to prevent the loss of PKC gamma during diabetes. The restoration of normal PKC gamma levels may prevent diabetic cataracts.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
1R01EY013421-01
Application #
6318735
Study Section
Visual Sciences A Study Section (VISA)
Program Officer
Liberman, Ellen S
Project Start
2001-05-01
Project End
2004-04-30
Budget Start
2001-05-01
Budget End
2002-04-30
Support Year
1
Fiscal Year
2001
Total Cost
$266,380
Indirect Cost
Name
Kansas State University
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
City
Manhattan
State
KS
Country
United States
Zip Code
66506
Schiffman, E L; Velly, A M; Look, J O et al. (2014) Effects of four treatment strategies for temporomandibular joint closed lock. Int J Oral Maxillofac Surg 43:217-26
Banerjee, Debarshi; Das, Satyabrata; Molina, Samuel A et al. (2011) Investigation of the reciprocal relationship between the expression of two gap junction connexin proteins, connexin46 and connexin43. J Biol Chem 286:24519-33
Burr, Diana B; Molina, Samuel A; Banerjee, Debarshi et al. (2011) Treatment with connexin 46 siRNA suppresses the growth of human Y79 retinoblastoma cell xenografts in vivo. Exp Eye Res 92:251-9
Das, Satyabrata; Wang, Huan; Molina, Samuel A et al. (2011) PKC?, role in lens differentiation and gap junction coupling. Curr Eye Res 36:620-31
Lauer, Jason; Banerjee, Debarshi; Shanks, Denton et al. (2010) NMR structure/function relationships of peptides corresponding to the C1B1 Region of PKC gamma. Protein Pept Lett 17:1-10
Banerjee, Debarshi; Gakhar, Gunjan; Madgwick, Dan et al. (2010) A novel role of gap junction connexin46 protein to protect breast tumors from hypoxia. Int J Cancer 127:839-48
Zhang, Yunong; Snider, Adam; Willard, Lloyd et al. (2009) Loss of Purkinje cells in the PKCgamma H101Y transgenic mouse. Biochem Biophys Res Commun 378:524-8
Akoyev, Vladimir; Das, Satyabrata; Jena, Snehalata et al. (2009) Hypoxia-regulated activity of PKCepsilon in the lens. Invest Ophthalmol Vis Sci 50:1271-82
Das, Satyabrata; Lin, Dingbo; Jena, Snehalata et al. (2008) Protection of retinal cells from ischemia by a novel gap junction inhibitor. Biochem Biophys Res Commun 373:504-8
Barnett, Michael; Lin, Dingbo; Akoyev, Vladimir et al. (2008) Protein kinase C epsilon activates lens mitochondrial cytochrome c oxidase subunit IV during hypoxia. Exp Eye Res 86:226-34

Showing the most recent 10 out of 27 publications